Table 2.
Postprandial triglycerides, HDL-chol, NEFA, and apolipoproteins.
| PCOS (n = 26) | Controls (n = 26) | p | |
|---|---|---|---|
| TG 0 hrs (mmol/L)∗ | 1.57 ± 0.15 | 1.20 ± 0.08 | 0.075 |
| TG 2 hrs (mmol/L)∗ | 2.18 ± 0.18 | 1.58 ± 0.10 | 0.019 |
| TG 4 hrs (mmol/L)∗ | 2.41 ± 0.22 | 1.83 ± 0.14 | 0.057 |
| TG 6 hrs (mmol/L)∗ | 1.96 ± 0.23 | 1.49 ± 0.16 | 0.074 |
| TG 8 hrs (mmol/L)∗ | 1.74 ± 0.22 | 1.30 ± 0.13 | 0.129 |
| AUC-TG (mmol/L·8 hrs)∗ | 8.20 ± 0.77 | 6.15 ± 0.45 | 0.041 |
| iAUC-TG (mmol/L·8 hrs) | 1.93 ± 0.28 | 1.35 ± 0.24 | 0.127 |
| HDL-chol 0 hrs (mmol/L) | 1.34 ± 0.06 | 1.51 ± 0.06 | 0.046 |
| HDL-chol 2 hrs (mmol/L) | 1.27 ± 0.06 | 1.44 ± 0.05 | 0.037 |
| HDL-chol 4 hrs (mmol/L) | 1.22 ± 0.06 | 1.37 ± 0.05 | 0.043 |
| HDL-chol 6 hrs (mmol/L) | 1.25 ± 0.06 | 1.42 ± 0.05 | 0.034 |
| HDL-chol 8 hrs (mmol/L) | 1.30 ± 0.06 | 1.44 ± 0.05 | 0.092 |
| AUC-HDL-chol (mmol/L·8 hrs) | 5.06 ± 0.23 | 5.71 ± 0.21 | 0.041 |
| iAUC-HDL-chol (mmol/L·8 hrs) | −0.32 ± 0.03 | −0.33 ± 0.07 | 0.883 |
| NEFA 0 hrs (mmol/L) | 0.65 ± 0.04 | 0.61 ± 0.05 | 0.644 |
| NEFA 2 hrs (mmol/L) | 0.19 ± 0.02 | 0.18 ± 0.05 | 0.658 |
| NEFA 4 hrs (mmol/L) | 0.33 ± 0.03 | 0.36 ± 0.05 | 0.524 |
| NEFA 6 hrs (mmol/L) | 0.62 ± 0.05 | 0.67 ± 0.05 | 0.544 |
| NEFA 8 hrs (mmol/L) | 0.81 ± 0.05 | 0.84 ± 0.05 | 0.698 |
| AUC NEFA (mmol/L·8 hrs) | 1.87 ± 0.10 | 1.94 ± 0.05 | 0.681 |
| iAUC NEFA (mmol/L·8 hrs) | −0.72 ± 0.14 | −0.52 ± 0.05 | 0.400 |
| ApoB-48 0 hrs (μg/mL)∗ | 11.9 ± 1.45 | 9.89 ± 1.29 | 0.252 |
| ApoB-48 2 hrs (μg/mL)∗ | 17.0 ± 1.43 | 15.7 ± 1.08 | 0.468 |
| ApoB-48 4 hrs (μg/mL)∗ | 19.2 ± 1.56 | 15.8 ± 1.55 | 0.058 |
| ApoB-48 6 hrs (μg/mL)∗ | 18.3 ± 1.70 | 15.8 ± 1.93 | 0.184 |
| ApoB-48 8 hrs (μg/mL)∗ | 12.9 ± 1.34 | 11.3 ± 1.48 | 0.239 |
| AUC-apoB-48 (μg/mL·8 hrs)∗ | 66.4 ± 5.32 | 57.6 ± 4.41 | 0.157 |
| iAUC-apoB-48 (μg/mL·8 hrs) | 19.35 ± 3.38 | 18.27 ± 2.45 | 0.796 |
| ApoB 0 hrs (g/dL) | 0.73 ± 0.07 | 0.82 ± 0.06 | 0.328 |
| ApoB 2 hrs (g/dL) | 0.76 ± 0.07 | 0.73 ± 0.06 | 0.816 |
| ApoB 4 hrs (g/dL) | 0.83 ± 0.06 | 0.76 ± 0.06 | 0.364 |
| ApoB 6 hrs (g/dL) | 0.79 ± 0.05 | 0.77 ± 0.05 | 0.779 |
| ApoB 8 hrs (g/dL) | 0.83 ± 0.05 | 0.79 ± 0.05 | 0.603 |
| AUC-apoB (g/dL·8 hrs) | 3.16 ± 0.17 | 3.07 ± 0.14 | 0.688 |
| iAUC-apoB (g/dL·8 hrs) | 0.22 ± 0.22 | −0.22 ± 0.19 | 0.143 |
| ApoA-I 0 hrs (g/dL) | 1.15 ± 0.07 | 1.10 ± 0.10 | 0.679 |
| ApoA-I 2 hrs (g/dL) | 1.04 ± 0.09 | 1.14 ± 0.09 | 0.437 |
| ApoA-I 4 hrs (g/dL) | 1.19 ± 0.08 | 1.28 ± 0.08 | 0.465 |
| ApoA-I 6 hrs (g/dL) | 1.18 ± 0.08 | 1.22 ± 0.08 | 0.715 |
| ApoA-I 8 hrs (g/dL) | 1.08 ± 0.08 | 1.16 ± 0.09 | 0.481 |
| AUC-apoA-I (g/dL·8 hrs) | 4.52 ± 0.19 | 4.75 ± 0.18 | 0.391 |
| iAUC-apoA-I (g/dL·8 hrs) | −0.08 ± 0.30 | 0.35 ± 0.34 | 0.342 |
| ApoA-II 0 hrs (g/dL) | 0.32 ± 0.02 | 0.30 ± 0.03 | 0.544 |
| ApoA-II 2 hrs (g/dL) | 0.29 ± 0.03 | 0.30 ± 0.02 | 0.796 |
| ApoA-II 4 hrs (g/dL) | 0.26 ± 0.03 | 0.25 ± 0.03 | 0.764 |
| ApoA-II 6 hrs (g/dL) | 0.26 ± 0.02 | 0.30 ± 0.02 | 0.195 |
| ApoA-II 8 hrs (g/dL) | 0.25 ± 0.02 | 0.26 ± 0.02 | 0.761 |
| AUC-apoA-II (g/dL·8 hrs) | 1.10 ± 0.04 | 1.13 ± 0.04 | 0.657 |
| iAUC-apoA-II (g/dL·8 hrs) | −0.19 ± 0.09 | −0.08 ± 0.09 | 0.410 |
∗ t-tests analysis after log transformation.